SMAD1 as a biomarker and potential therapeutic target in drug-resistant multiple myeloma

被引:0
|
作者
Jian Wu
Min Zhang
Omar Faruq
Eldad Zacksenhaus
Wenming Chen
Aijun Liu
Hong Chang
机构
[1] University of Toronto,Department of Laboratory Medicine and Pathobiology
[2] Capital Medical University,Department of Hematology, Beijing Chaoyang Hospital
[3] University Health Network,Department of Laboratory Hematology, Laboratory Medicine Program
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] hsa_circRNA_101237: A Novel Diagnostic and Prognostic Biomarker and Potential Therapeutic Target for Multiple Myeloma
    Liu, Xiao
    Tang, Hao
    Liu, Jing
    Wang, Xiang
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 2109 - 2118
  • [22] Mycobacteriophages as Potential Therapeutic Agents against Drug-Resistant Tuberculosis
    Allue-Guardia, Anna
    Saranathan, Rajagopalan
    Chan, John
    Torrelles, Jordi B.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (02) : 1 - 28
  • [23] Upregulation of lncRNA NR_046683 Serves as a Prognostic Biomarker and Potential Drug Target for Multiple Myeloma
    Dong, Hang
    Jiang, Siyi
    Fu, Yunfeng
    Luo, Yanwei
    Gui, Rong
    Liu, Jing
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [24] Nucleotide excision repair is a potential therapeutic target in multiple myeloma
    Szalat, R.
    Samur, M. K.
    Fulciniti, M.
    Lopez, M.
    Nanjappa, P.
    Cleynen, A.
    Wen, K.
    Kumar, S.
    Perini, T.
    Calkins, A. S.
    Reznichenko, E.
    Chauhan, D.
    Tai, Y-T
    Shammas, M. A.
    Anderson, K. C.
    Fermand, J-P
    Arnulf, B.
    Avet-Loiseau, H.
    Lazaro, J-B
    Munshi, N. C.
    LEUKEMIA, 2018, 32 (01) : 111 - 119
  • [25] Nucleotide excision repair is a potential therapeutic target in multiple myeloma
    R Szalat
    M K Samur
    M Fulciniti
    M Lopez
    P Nanjappa
    A Cleynen
    K Wen
    S Kumar
    T Perini
    A S Calkins
    E Reznichenko
    D Chauhan
    Y-T Tai
    M A Shammas
    K C Anderson
    J-P Fermand
    B Arnulf
    H Avet-Loiseau
    J-B Lazaro
    N C Munshi
    Leukemia, 2018, 32 : 111 - 119
  • [26] The potential of inhibiting glutamine uptake as a therapeutic target for multiple myeloma
    Giuliani, Nicola
    Chiu, Martina
    Bolzoni, Marina
    Accardi, Fabrizio
    Bianchi, Massimiliano G.
    Toscani, Denise
    Aversa, Franco
    Bussolati, Ovidio
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2017, 21 (03) : 231 - 234
  • [27] BMP4/Smad1 Signaling: A Novel Therapeutic Target for the Progression of Diabetic Nephropathy
    Matsubara, Takeshi
    Abe, Hideharu
    Tominaga, Tatsuya
    Jishage, Kou-ichi
    Mima, Akira
    Ueda, Otoya
    Araki, Makoto
    Torikoshi, Kazuo
    Nagai, Kojiro
    Goto, Chisato
    Kinosaki, Masahiko
    Iehara, Noriyuki
    Fukushima, Naoshi
    Fukastu, Atsushi
    Arai, Hidenori
    Doi, Toshio
    DIABETES, 2011, 60 : A2 - A2
  • [28] CS1, a potential new therapeutic antibody target for the treatment of multiple myeloma
    Hsi, Eric D.
    Steinle, Roxanne
    Balasa, Balaji
    Szmania, Susann
    Draksharapu, Aparna
    Shum, Benny P.
    Huseni, Mahrukh
    Powers, David
    Nanisetti, Amulya
    Zhang, Yin
    Rice, Audie G.
    van Abbema, Anne
    Wong, Melanie
    Liu, Gao
    Zhan, Fenghuang
    Dillon, Myles
    Chen, Shihao
    Rhodes, Susan
    Fuh, Franklin
    Tsurushita, Naoya
    Kumar, Shankar
    Vexler, Vladimir
    Shaughnessy, John D., Jr.
    Barlogie, Bart
    van Rhee, Frits
    Hussein, Mohamad
    Afar, Daniel E. H.
    Williams, Marna B.
    CLINICAL CANCER RESEARCH, 2008, 14 (09) : 2775 - 2784
  • [29] The heat shock transcription factor 1 as a potential new therapeutic target in multiple myeloma
    Heimberger, Tanja
    Andrulis, Mindaugas
    Riedel, Simone
    Stuehmer, Thorsten
    Schraud, Heike
    Beilhack, Andreas
    Bumm, Thomas
    Bogen, Bjarne
    Einsele, Hermann
    Bargou, Ralf C.
    Chatterjee, Manik
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 160 (04) : 465 - 476
  • [30] The histone methyltransferase DOT1L is a potential therapeutic target in multiple myeloma
    Ishiguro, Kazuya
    Sasaki, Hajime
    Wakasugi, Hideki
    Kitajima, Hiroshi
    Niinuma, Takeshi
    Maruyama, Reo
    Kai, Masahiro
    Ikeda, Hiroshi
    Ishida, Tadao
    Sasaki, Yasushi
    Tokino, Takashi
    Nakase, Hiroshi
    Suzuki, Hiromu
    CANCER SCIENCE, 2018, 109 : 690 - 690